Intractable RA - treatment with combined methotrexate, azathioprine and hydroxychloroquine

Rheumatology

Volumn 28, Issue 3, 1989, Pages 271-272

  Langevitz, P ^a   Kaplinsky, N ^a   Ehrenfeld, M ^a   Pras, M ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; HYDROXYCHLOROQUINE; METHOTREXATE; PREDNISONE;

DRUG MIXTURE; HUMAN; LETTER; NAUSEA; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS;

ADULT; ARTHRITIS, RHEUMATOID; AZATHIOPRINE; DRUG THERAPY, COMBINATION; FEMALE; HUMAN; HYDROXYCHLOROQUINE; METHOTREXATE; MIDDLE AGE;

EID: 0024353186     PISSN: 14620324     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/28.3.271     Document Type: Letter

References (9)

1. Lewis P, Hazlenian B, Bulgen, D. Clinical and immunological study of high dose azathioprine combined with gold therapy in rheumatoid arthritis. In: Cellular pathology and pharmacology. Amsterdam: North Holland, 1977: 280.
2. McCarty DJ, Carrera GF. Intractable rheumatoid arthritis treatment with combined cyclophosphamide, azathioprine and hydroxychloroquine. Preliminary communication, JAMA 1982; 248:1718-23.
3. Csuta MF, Carrera GF, McCarty DJ. Treatment of intractable rheumatoid arthritis with combined cyclophosphamide, azathioprine and hydroxychloroquine. A follow up study. JAMA 1986; 255:2315-19.
4. Butler D, Tiliakos A. Low-dose cytotoxic drug combination therapy in intractable rheumatoid arthritis. Arthritis Rheum 1985; 28 (suppl): S15.
5. Bitter T. Combined disease-modifying chemotherapy for intractable rheumatoid arthritis. Clins Rheum Dis 1984; 10:417-29.
6. Krishna S, Davis TME, Chan PCY, Wells RA, Robson KJH. Ciprofloxacin and malaria. Lancet 1988;2: 1231-2.
7. Roche Y, Fay M, Gougerot-Pocidalo MA. Effects of quinolones on interleukin I production in vitro by human monocytes. Immunopharmacology 1987;13: 99-109.
8. Forsgren A, Bredberg A, Pardee A, Schlossman S, Tedder T Effects of ciprofloxacin on eukaryotic pyrimidine nucleotide biosynthesis and cell growth. Antimicrob Agents Chemother 1987;31:774-9.
9. Ball P. Ciprofloxacin: an overview of adverse experiences. J Antimicrob Chem 1986;18(Suppl D):187-93.